Flowserve Corporation (FLS) Guidance & Earnings Results

On 2026-07-29 Flowserve Corporation mixed guidance: "FY26 organic sales growth revised to approx. -1% from -1% to +2%; FY26 adjusted EPS raised to $4.05-$4.20 from $4.00-$4.20; FY26 capex ~$100M from $90M-$100M; net interest expense ~$85M; adjusted tax rate…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

FLSFlowserve CorporationFollow FLS — free

Specialty Industrial Machinery · Industrials

—

Price chart with a free account

Market cap: 8.7B
P/E TTM: 23.8
Dividend yield: 1.3%
52-week: —
Next earnings: 28 Oct, in 4 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
29 Jul 26	Mixed	FY26 organic sales growth revised to approx. -1% from -1% to +2%; FY26 adjusted EPS raised to $4.05-$4.20 from $4.00-$4.20; FY26 capex ~$100M from $90M-$100M; net interest expense ~$85M; adjusted tax rate 21%-22% · full year
5 Feb 26	Raised	2026 adjusted EPS $4.00-$4.20, total sales growth 5-7% · full year
28 Oct 25	Raised	Adjusted EPS raised from $3.25-$3.40 to $3.40-$3.50; organic sales growth revised from +3-4% to ~2% · full year
29 Jul 25	Raised	FY25 adjusted EPS raised to $3.25-$3.40 from $3.10-$3.30; organic sales growth narrowed to +3% to +4% from +3% to +5%; total sales growth +5% to +6% from +5% to +7%; capex unchanged $80-$90M; adjusted tax rate approx. 20% from approx. 21% · full year

Flowserve Corporation — questions

What guidance did Flowserve Corporation give?: On 2026-07-29: "FY26 organic sales growth revised to approx. -1% from -1% to +2%; FY26 adjusted EPS raised to $4.05-$4.20 from $4.00-$4.20; FY26 capex ~$100M from $90M-$100M; net interest expense ~$85M; adjusted tax rate 21%-22%"
When does Flowserve Corporation report earnings?: Flowserve Corporation's next earnings report is expected on 2026-10-28.

Every figure on this page comes from Flowserve Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.